Home HRCompany Profiles Look ahead to FTSE 350 & other companies reporting from 24 to 28 January

Look ahead to FTSE 350 & other companies reporting from 24 to 28 January

by admin

Look ahead to FTSE 350 & other companies reporting from 24 to 28 January 

  • We’ll see if inflationary tailwinds have helped Microsoft as planned
  • CVS Group will let us know if the UK pet boom still has room to run
  • Will Dr Martens continue to stomp ahead
  • Diageo looks to push on with its recovery

Microsoft, Q2 Results, Tuesday 25th January

Sophie Lund-Yates, Equity Analyst

“Back in the first quarter, Microsoft said it hoped to benefit from rising inflation. The logic being, as businesses sought to become more efficient as costs rise, they’d flock to Microsoft’s software products like its cloud-based computer power. Inflation’s certainly been running rampant, so next week we’ll find out if those expectations have become a reality. The market’s hopes will be high, as it’s become accustomed to Microsoft’s stellar results. Last quarter, revenue rose 20% to $45.3bn, ignoring the effect of exchange rates, which was faster than market expectations. There was double digit growth in every division and group operating profit rose 24% to $20.2bn. We should also get some insight into how it plans to further expand its metaverse, following news of the impending almost $70bn acquisition of Call of Duty maker, Activision Blizzard.”

CVS Group, Trading Statement, Thursday 27th January

Sophie Lund-Yates, Equity Analyst

“CVS Group’s price/earnings ratio may have come down from the ten-year highs of last year, but at 24.5 the pressure’s still on to live up to expectations. Sales rose almost 14% in the first few months of the financial year, partly thanks to the boom in UK pet ownership over lockdowns.  We’ll be particularly interested to see how the fast growing virtual vet pharmacy has been doing. Puppies and kittens tend to need the most attention when they’re very young, so if the pet-boom has slowed, we wonder if like-for-likes have started to temper at all. The final thing is vacancies. The biggest risk for CVS and vets in general, is a shortage of qualified vets. The group’s done a lot to help keep retention and vacancies at acceptable levels, but it’s something worth keeping an eye on.”

Dr Martens, Q3 Trading Statement, Thursday 27th January

Susannah Streeter, Senior Investment and Markets Analyst

‘’Dr Martens stomped ahead with a surge in pre-tax profits at its half year results, but supply chain issues have still slipped up the bootmaker with lockdowns closing production sites in Vietnam and backlogs at ports leading to stock shortages. Signs that these problems have eased will be encouraging for investors, because underlying demand for styles remain strong. The iconic nature of the brand should also insulate it from the effects of price rises, with consumers prepared to pay more for coveted fashion. Direct to consumer sales will be closely watched as e-commerce is central to Dr Martens’ strategy. The recent share price slide was sparked by an early investor offloading a small part of a significant holding, rather than any underlying concerns about the direction of the company.’’

Diageo, Half Year Results, Thursday 27th January

Matt Britzman, Equity Analyst

“Management warned of near-term volatility in their previous full-year results and with inflationary pressures pushing costs up, we’ll be looking out for any impact on operating margins. Following periods of hefty restrictions, the return of customers to bars and restaurants should be positive for the on-trade sales numbers. Although, in light of Omicron developments, it’ll be interesting to see how much of an impact this has had on recovery. The balance sheet looked in good shape last year. Debt had been creeping higher than we’d like but it was pleasing to see net debt coming down in more recent results. We’re hopeful that can come down further if profits continue to move in the right direction. Net sales are forecast to rise in the region of 13.2%, to £7.8bn but a price to earnings ratio of 26.0 means markets will be expecting good things and any major deviation from guidance risks disappointing the markets.”

24-Jan
ComputacenterQ4 Trading Statement
  
25-Jan
Capricorn EnergyTrading Statement
Microsoft*Q2 Results
TI Fluid SystemsPost-Close Trading Statement
Verizon*Q4 Results
26-Jan
Brewin Dolphin HoldingsQ1 Trading Statement
CMC MarketsQ3 Trading Statement
FresnilloQ4 Production Statement
Pets at Home*Q3 Trading Statement
QuilterQ4 Trading update
SageQ1 Trading Statement
Tesla*Q4 Results
Wizz AirQ3 Results
27-Jan
3i GroupQ3 Trading Statement
Anglo AmericanQ4 Production Statement
Apple*Q1 Results
BritvicQ1 Results
CVS Group*Trading Statement
Diageo*Half Year Results
Dr MartensQ3 Trading Statement
Euromoney Institutional InvestorQ1 Trading Statement
GreencoreQ1 Trading Statement
IGHalf Year Results
Intermediate Capital GroupTrading Statement
Keywords Studios*Full Year Trading Statement
LVMH*Full Year Results
McDonalds*Q4 Results
Mitie GroupQ3 Results
Polymetal InternationalQ4 Earnings
Rank GroupHalf Year Results
Saga*Trading update
St. James’s PlaceQ4 New Business Update
Visa*Q1 Results
28-Jan
Paragon Banking GroupQ1 Trading Statement
  

*Events on which we will be updating investors

You may also like

Leave a Comment